Buy animal genetics firm Genus ahead of its next exciting growth phase
Shareholders in leading global animal genetics specialist Genus (GNS) have been through a rough couple of years with the shares losing just under two-thirds of their value.The fall can be attributed to a big derating in the shares...
12 October 2023